Know Where Topical Delgocitinib Fits for Chronic Hand Eczema
December 2025
Delgocitinib (Anzupgo) is the first topical cream approved specifically for CHRONIC hand eczema (CHE) in adults.
Up until now, only oral alitretinoin (Hanzema) has been approved for this hand condition.
CHE is eczema on the hands that lasts for more than 3 months or relapses twice or more in a year. And it causes itching, pain, drying and cracking of the skin, as well as redness.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive